Stockholders' Equity (Deficit) - Schedule of warrants (Detail) - Warrant	9 Months Ended	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares
Number
Beginning balance (in shares) | shares		7,444,698	5,678,836
Granted (in shares) | shares		11,631,035	1,765,862
Exercised (in shares) | shares	6,437,501	10,331,035	0
Ending balance (in shares) | shares	8,744,698	8,744,698	7,444,698
Intrinsic value of warrants | $	$ 6,661,661	$ 6,661,661	$ 327,214
Weighted Average Remaining Contractual Life (Years)		3 years 10 months 9 days
Weighted Average Exercise Price
Beginning balance (in usd per share) | $ / shares		$ 1.68	$ 1.84
Granted | $ / shares		0.34	1.17
Exercised (in usd per share) | $ / shares		0.41	0
Ending balance (in usd per share) | $ / shares	$ 1.40	$ 1.40	$ 1.68